Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	10.26B +50.0%
Revenue (ttm)	4.10B +47.9%
Net Income	268.61M -23.0%
EPS	0.13 -26.2%
Shares Out	2.00B
PE Ratio	38.40
Forward PE	17.90
Dividend	0.04 (0.78%)
Ex-Dividend Date	n/a

Volume	7,276,189
Average Volume	14,442,730
Open	5.09
Previous Close	5.09
Day's Range	5.06 - 5.15
52-Week Range	3.02 - 5.18
Beta	0.38
RSI	71.29
Earnings Date	May 21, 2026

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, engages in producing, marketing, selling, and storing pharmaceutical reagents for human and veterinary use. It is also involved in producing, marketing, selling, and storing diagnostic reagents for individuals, laboratories, and hospitals; importing pharmaceutical reagents and raw materials; producing pharmaceutical reagents for human, veterinary, and diagnostic use; and producing food supplements for human use. The company w...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2025, EGX:RMDA's revenue was 4.10 billion, an increase of 47.94% compared to the previous year's 2.77 billion. Earnings were 268.61 million, a decrease of -26.17%.